#MedComm
LightNews LightNews
rnamod.bsky.social
Extracellular Vesicles: Classification, Biological Functions, Diseases, and Therapeutic Opportunities

MedComm · Garbo et al.
doi.org/10.1002/mco2.70896
#RNAsky #RNAmods
Extracellular Vesicles: Classification, Biological Functions, Diseases, and Therapeutic Opportunities
MedComm · Garbo S, Marocco F, Zwergel C, Tripodi M, Battistelli C.
doi.org
September 23, 2026 at 1:19 PM
c-j-fisher.bsky.social
Hey #SciComm and #MedComm folks, how do you communicate uncertainty?

Uncertainty is a tricky topic. I mean, heck, when discussing uncertainty in a general sense, you're defining a word that describes how things are hard to fully define.

That's pretty meta, if you ask me!

🧪 (1/7)
May 2, 2025 at 5:42 PM
tomkindlon.bsky.social
Press release:
New review highlights variant-specific differences in long COVID, underscoring vaccine role and future directions for research and care

onlinelibrary.wiley.com/doi/full/10....

#LongCovid #PASC #PwLC
News Release 10-Dec-2024 New review highlights variant-specific differences in long COVID, underscoring vaccine role and future directions for research and care Peer-Reviewed Publication Sichuan International Medical Exchange and Promotion Association Long COVID, or post-acute sequelae of COVID-19 (PASC), has become a significant public health concern as persistent symptoms affect millions worldwide, long after the acute phase of infection subsides. A review published in MedComm – Future Medicine, led by a team at the Faculty of Medicine at Macau University of Science and Technology, examines how long COVID symptoms differ between SARS-CoV-2 variants, drawing on data from a range of populations and study designs. Dr. Olivia Monteiro, co-corresponding author of this review explained, “As COVID-19 variants emerged, they demonstrated distinct behaviors in terms of immune evasion, transmissibility, and pathogenicity. Our review aims to synthesize these observations and explore the interplay between variants, vaccination, and long COVID.”
December 12, 2024 at 2:29 AM
lfv-rhetrx.bsky.social
Reminder to the people inexplicably following me here: I’m a rhetorician who taught tech/sci/business/medical and environmental science writing, worked in medcomm, and is currently editing a chemistry paper. I miss teaching, but not academia…
February 15, 2024 at 6:42 PM
rnamod.bsky.social
METTL3-Mediated N6-Methyladenosine Modification Activates the EGR1-ZBP1 Axis to Promote PANoptosis-Like Cardiomyocyte Death in Myocardial Ischemia-Reperfusion Injury

MedComm · Li et al.
doi.org/10.1002/mco2.70962
#RNAsky #RNAmods
METTL3-Mediated N6-Methyladenosine Modification Activates the EGR1-ZBP1 Axis to Promote PANoptosis-Like Cardiomyocyte Death in Myocardial Ischemia-Reperfusion Injury
Here, we investigated whether METTL3-mediated m6A modification contributes to PANoptosis-like cardiomyocyte death during I/R injury.
doi.org
September 23, 2026 at 1:19 PM
medcomm.bsky.social
#Article in @medcomm.bsky.social #MedComm
#Spironolactone and #Fibrosis in Heart Failure Risk: #MachineLearning Analysis of #HOMAGE Trial Plasma Proteomics doi.org/10.1002/mco2...

Researchers from CIMA Universidadde Navarra and IdiSNA, Spain

#biomarker #HeartFailure #MLA #PICP
Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics
In HOMAGE, 276 plasma proteins were profiled using Olink panels. Machine learning algorithms identified galectin-9 (GAL9), thrombospondin-2 (THBS2), and NT-proBNP as predictors of changes in procolla....
doi.org
March 20, 2026 at 3:32 AM
hirespace.bsky.social
Follow HireSpace to see how we connect health organizations with top talents to enhance health communication. Interested in joining as a talent or working with our network of 100+ experts? Check out our website: hirespace.io! #healthcommunications #healthmarketing #medcomm #HireSpace #expertnetwork
HireSpace: Clients
Use HireSpace to find trusted freelancers for your health communication needs.
hirespace.io
December 4, 2024 at 8:23 PM
mizmedsci.bsky.social
New USPSTF recs on osteoporosis. Now, as a handy #infographic. #Meded #MedComm
Screening for osteoporosis to prevent fractures, US preventative services Task force 2025 recommendation statement. Who should be screened women over 65 routine screening recommended with or without risk assessment grade B? Post menopausal women under 65 who are at risk. There is insufficient evidence to recommend screening in men. What screening is recommended Central d? X, a scan for bone density. Clinical risk assessment tools can predict Osteoporosis in women and predict certain fractures in women and men. Benefits of early detection and treatment are limited to women screening for fracture risk and treatment in women over 65 and postmenopausal women under 65, with risk factors provides moderate benefit for fracture prevention. Key takeaways, early screening prevents fracture and reduces healthcare burden. Focus on women aged sixty five and older and younger women.At risk, small horms from screening are outweighed by benefits
January 14, 2025 at 10:57 PM
lfv-rhetrx.bsky.social
I’d used EndNote In Humanities, medcomm, and scientific research settings, but the convenience factor kept crashing downwards
May 15, 2026 at 2:10 PM
lfv-rhetrx.bsky.social
I understand the need for shorthand, but it increases the likelihood of people talking cross-purposes. (I have fond memories of the DIA medcomm event at the Wild Horse Pass in Arizona)
February 20, 2024 at 4:02 PM
medcomm.bsky.social
#Highlight in @medcomm.bsky.social #MedComm

#OTOF Gene Therapy: From Breakthroughs to Roadmaps doi.org/10.1002/mco2...

The highlighted article in #NatureMedicine : doi.org/10.1038/s415...

#ClinicalTrials #GeneTherapy
March 20, 2026 at 3:54 AM
dzne.science
New paper out: Human Coronavirus 229E Uses ORF4/4a to Antagonize the Host Restriction Factor SERINC5.: Xie, Qinya; Noettger, Sabrina; Lawrenz, Jan; et al.
MedComm Vol. 7, no. 6, p. e70785 | Thanks for sharing #dzne #papers
Human Coronavirus 229E Uses ORF4/4a to Antagonize the Host Restriction Factor SERINC5.
Xie, Qinya; Noettger, Sabrina; Lawrenz, Jan; et al. MedComm Vol. 7, no. 6, p. e70785
dlvr.it
June 21, 2026 at 9:53 AM
medcomm.bsky.social
#Letter in @medcomm.bsky.social #MedComm
#Clinical, #Prognostic, and #Biological Features of High-Risk Cardiometabolic Phenotype: The #REMODEL Study doi.org/10.1002/mco2...

Researchers from Duke NUS Medical School
March 20, 2026 at 3:46 AM
rridrobot.bsky.social
A paper using RRID:Addgene_61549 was just published in MedComm see "Targeting WDPF domain of Hsp27 achieves a broad spectrum of antiviral". We appreciate the author's support of reproducibility. #accelerateopenscience #reproducibility
doi.org
March 31, 2025 at 7:00 AM
ndocist.eurosky.social
The Use of #largelanguaguemodels and Their Association With Enhanced Impact in Biomedical Research and Beyond | MedComm – Future Medicine
Les #academicwriting produites avec l'IA seraient plus citées... pour autant qu'on puisse les détecter et établir un lien cause-effet
The Use of Large Language Models and Their Association With Enhanced Impact in Biomedical Research and Beyond
This study analyzed articles from arXiv, bioRxiv, and medRxiv published between 2022 and 2024, using a novel tool for detecting LLM usage. We found that (1) LLMs have been widely adopted since late 2....
onlinelibrary.wiley.com
June 26, 2025 at 4:40 AM
rridrobot.bsky.social
The authors included RRIDs in their MedComm paper! We value the author's support of reproducibility. #methodsmatter #accelerateopenscience #STMpublishing
Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan‐Sarbecoviruses
doi.org
May 21, 2025 at 11:14 PM
mizmedsci.bsky.social
FFS. Here we go. Calling all of my #medcomm people, now is the time to start capturing these articles and getting the info out there in other forms before they can be retracted.
jeremyfaust.bsky.social Jeremy Faust, MD @jeremyfaust.bsky.social · Feb 1
BREAKING NEWS: CDC orders mass retraction and revision of submitted research across all science and medicine journals. Banned terms must be scrubbed.

Goes beyond MMWR +other CDC pubs. Applies to research already submitted to top medical journals.

Take a look.
open.substack.com/pub/insideme...
BREAKING NEWS: CDC orders mass retraction and revision of submitted research across all science and medicine journals. Banned terms must be scrubbed.
Any unpublished manuscript mentioning certain topics, including gender and "LGBT," must be pulled or revised.
open.substack.com
February 2, 2025 at 7:58 PM
ellenkuwana.bsky.social
Thinking words ("words, Roxanne" [Cyrano Steve Martin movie reference]) at #ACES2025. Like dropping hyphens in many words, and like pretest and still getting used to posttest... #hyphens @apstylebook.com #Editing #STEM #Science #MedEd #MedComm
apstylebook.com AP Stylebook @apstylebook.com · Mar 24
This change aligns style on those prefixes both with our overall guidance and with Merriam-Webster.
April 4, 2025 at 3:57 PM
rridrobot.bsky.social
The authors included RRIDs in their in MedComm paper! RRIDs improve reproducibility in scientific research. #OpenResearch #BetterScience #ReproducibleResearch
Increased Brown Adipose Tissue Thermogenesis in Phenylketonuria
Read the full paper: Increased Brown Adipose Tissue Thermogenesis in Phenylketonuria
doi.org
June 18, 2026 at 7:00 AM
rdshrestha88.bsky.social
📢Our latest review article in #MedComm-Wiley explores how EMT drives cancer progression, metastasis, and resistance to radiotherapy, and highlights emerging therapeutic strategies to overcome these challenges. #NIRINepal #CARE #Cancer #CancerTherapy #RT
Read more here 🔗 doi.org/10.1002/mco2...
August 29, 2025 at 12:18 PM
jorgebscomm.bsky.social
Feeling unheard at the doctor's office? This post empowers patients to advocate for themselves & improve communication with healthcare providers:
#MedComm #healthcare #communication #edusky
empowervmediacomm.blogspot.com/2024/04/effe...
Effective Communication in Healthcare Settings: Building Trust and Improving Patient Outcomes
Learn how effective communication builds trust & improves patient outcomes in healthcare settings. Evidence-based strategies for providers & patients.
empowervmediacomm.blogspot.com
April 11, 2024 at 8:06 AM
rridrobot.bsky.social
RRID:CVCL_0045 was used by the authors of the MedComm paper "Identifying the Intergenic ALK Fusion LOC388942-ALK as a Driver of Non–Small Cell Lung Cancer". Thank you for making your methods matter! #methodsmatter #STMpublishing
doi.org
April 8, 2025 at 7:01 AM
medcomm.bsky.social
#Review in #MedComm
Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges doi.org/10.1002/mco2...

#ArtificialIntelligence #AI #cancer #CancerDiagnosis #PrognosisPrediction #personalized #therapy
Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges
Artificial intelligence (AI) is a rising star in the field of medicine, avoiding misdiagnosis by human negligence, reducing the workload of doctors, and aiding clinicians in decision-making. AI can i...
doi.org
November 7, 2025 at 8:20 AM
medcomm.bsky.social
#Letter in #MedComm
Alterations in Tryptophan Metabolism and the Indole Pathway in #ColorectalCancer Patients: A Systematic Review and #Meta-analysis doi.org/10.1002/mco2..., studied by @DrAnimeshAchar1 and his group

#CRC #PRISMA #Metabolism #disease
December 5, 2025 at 6:55 AM
rridrobot.bsky.social
RRID:CVCL_3360 was used by the authors of the MedComm paper "RETRACTION: ENKUR Recruits FBXW7 to Ubiquitinate and Degrade MYH9 and Further Suppress MYH9-Induced Deubiquitination of β-Catenin to Block Gastric Cancer Metast…". We appreciate the author's support of reproducibility. #STMpublishing
doi.org
April 3, 2025 at 7:00 AM